Barbara Rangetiner and Josef Weinberger of the Austrian affiliate of Octapharma, the largest privately owned human protein products manufacturer in the world, discuss the strategic significance of Austria to the group, the nation’s historical excellence in plasma and hematology, and recent upgrades to the affiliate’s manufacturing and fractionation capabilities
Vienna holds a very special place in the history of Octapharma as it was the first international facility of the Group to open outside of Switzerland. How strategically important is the Austrian affiliate and its operations to the Group today?
"Vienna can be regarded as a center of excellence for plasma and hematology." Josef Weinberger
